In AML patients, chronic exposure to MICA/B decreases expression of NKG2D on NK cells (104) and the concentration of NKG2D soluble ligands in the peripheral blood correlates with reduced NK cell cytotoxicity in AML and CML (105). This evidence concerns the gene KLRK1 and chronic myelogenous leukemia, BCR-ABL1 positive.